Attended BIO 2024 for global business partnering

Share：

Xantho Biotechnology delegates participated in the BIO2024 in US San Diego together with the Taiwan representatives comprising government officials and other 40+ Taiwanese Biotech. During the 4-day event, Xantho Bio has attended the one-on-one partnering meetings with global pharma to discuss potential business collaboration and licensing opportunities, demonstrating strong demands for Xantho’s new drugs in the global market.

43997A41-38D4-46C0-9E24-35916EC0FAB5 6E182535-354A-4CB3-8315-C5839649A9D5

Disclaimer

This article and related information on this site contain forward-looking statements. The forward-looking information requires the Company to make numerous assumptions and is subject to inherent risks, uncertainties, and other factors that are beyond the control of the Company which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. The Company undertakes no obligation to timely inform, update, or revise the information on this site if circumstances should change.

Related Information

Xantho Bio. participated and presented in NPIC 2024 International Symposium on Natural Product Innovation and Commercialization

November 2024

Exhibition

Xantho Biotechnology attended Bio Japan 2024 for global business partnering

The CEO and BD manager of Xantho Bio. attended Bio Japan 2024, one of the largest Bio convention in Asia, held in PACIFICO Yokohama Convention Center, Japan (from October 9 to October 11). During the 3-day event, Xantho Bio. participated in the one-on-one partnering meetings with international pharmaceutical companies to discuss drug licensing opportunities.

October 2024

Exhibition